CareSpan Health Inc. announced the execution of a Memorandum of Understanding dated May 19, 2023 with ChopraX, LLC to develop and launch a global telehealth platform focused mainly on preventive health, longevity, mental health, management of diabetes and other lifestyle diseases. Pursuant to the MOU, the Company and ChopraX will subsequently negotiate the terms and conditions of a definitive agreement to be completed by June 19, 2023 or at a later date as agreed upon by both parties. It is intended that ChopraX will have an equity stake in the Company, subject to shareholder and regulatory approval.

Among other assets and capabilities, the Company will contribute its integrated digital platform, as well as healthcare operations and technology expertise, while ChopraX will contribute the Chopra brand, clinical protocols, healthcare expertise and relationships with integrative medicine providers. The goal of the Proposed ChopraX-CareSpan Telehealth Platform is to help people live productive longer lives, by enabling a global network of approved integrative medicine practitioners and complementary therapy practitioners to provide high-touch patient services virtually.